Ownership history in XTX Topco Ltd · 13 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 9,690 | +5,165 | +114.1% | 0.20% | $3.8M | $391.64 |
| 2025 Q2 | ADDED | 4,525 | +1,995 | +78.9% | 0.08% | $2.0M | $445.20 |
| 2024 Q4 | REDUCED | 2,530 | -5,919 | -70.1% | 0.08% | $1.0M | $402.70 |
| 2024 Q2 | ADDED | 8,449 | +5,731 | +210.9% | 0.34% | $4.0M | $468.72 |
| 2023 Q4 | REDUCED | 2,718 | -4,351 | -61.6% | 0.24% | $1.1M | $406.89 |
| 2023 Q3 | ADDED | 7,069 | +4,270 | +152.6% | 0.42% | $2.5M | $347.74 |
| 2023 Q2 | ADDED | 2,799 | +1,170 | +71.8% | 0.18% | $985K | $351.91 |
| 2023 Q1 | ADDED | 1,629 | +774 | +90.5% | 0.11% | $513K | $315.07 |
| 2022 Q4 | REDUCED | 855 | -1,054 | -55.2% | 0.05% | $247K | $288.78 |
| 2022 Q3 | ADDED | 1,909 | +967 | +102.7% | 0.14% | $553K | $289.54 |
As of 2025 Q4 — sorted by position size